Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levetiracetam as Adjuvant Therapy to Hypothermia for Neonatal Asphyxia
NCT07897032Not yet recruiting
- Sponsor
- Alexandria University
- Start
- Nov 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Randomised trial of levetiracetam in hypoxic-ischemic encephalopathy (HIE) (2 arms), sponsored by Alexandria University. Primary endpoint: Neurodevelopmental Outcome at 6 months. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
levetiracetam
03
Conditions
hypoxic-ischemic encephalopathy (HIE)
Beyond the preview
Go deeper on NCT07897032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07897032.